<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective was to study <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (APS or <z:e sem="disease" ids="C0796280" disease_type="Disease or Syndrome" abbrv="">Hughes syndrome</z:e>) in two major teaching hospitals in Kuwait. patients with suspected <z:e sem="disease" ids="C0796280" disease_type="Disease or Syndrome" abbrv="">Hughes syndrome</z:e> were investigated with tests for anticardiolipin antibodies (aCL) and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> (LAC) over 1 yr </plain></SENT>
<SENT sid="1" pm="."><plain>Diagnosis was considered confirmed if significant levels of either or both antibodies with no obvious cause (primary), or with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) or SLE-like illness (including SLE serology) (secondary) were present </plain></SENT>
<SENT sid="2" pm="."><plain>Twelve (37.5%; seven females, 58%) primary and 20 (62.5%; 18 females, 90%) secondary <z:e sem="disease" ids="C0796280" disease_type="Disease or Syndrome" abbrv="">Hughes syndrome</z:e> patients were seen during this period. patients were Kuwaiti, Middle-Eastern and North-African Arabs (29) </plain></SENT>
<SENT sid="3" pm="."><plain>Filipinos (2) and White (1) </plain></SENT>
<SENT sid="4" pm="."><plain>None were from the Indian subcontinent </plain></SENT>
<SENT sid="5" pm="."><plain>The main presentation was <z:mp ids='MP_0005048'>thrombosis</z:mp> in 75% (arterial in 25% and venous in 50%), and <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortions</z:e> in 50% of married women </plain></SENT>
<SENT sid="6" pm="."><plain>Haematological and dermatological manifestations were limited entirely to the secondary variety, seen in 25% and 19%, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Clinical manifestations were severe, leading to <z:hpo ids='HP_0011420'>death</z:hpo> in one, intensive-care management in 31% and with partial or complete <z:chebi fb="8" ids="10033">warfarin</z:chebi> resistance or brittleness in 25% </plain></SENT>
<SENT sid="8" pm="."><plain>Neurological/eye and cardiac manifestations were not seen, as these patients may be attending separate speciality hospitals for these diseases in Kuwait </plain></SENT>
<SENT sid="9" pm="."><plain>The approximate prevalence of this syndrome was 2.66/1000 admissions in medical wards </plain></SENT>
<SENT sid="10" pm="."><plain>Projected to the total referral areas of the two hospitals, an approximate figure of 52 patients/million population/year was obtained </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="C0796280" disease_type="Disease or Syndrome" abbrv="">Hughes syndrome</z:e> was a common problem among Arabs, Filipinos and possibly Whites in Kuwait </plain></SENT>
<SENT sid="12" pm="."><plain>Its manifestations were severe, often requiring intensive-care management, and in one case it was fatal </plain></SENT>
<SENT sid="13" pm="."><plain>Patients from the Indian subcontinent were conspicuous by their absence, despite the fact that they were well represented in <z:hpo ids='HP_0000001'>all</z:hpo> other <z:e sem="disease" ids="C0035435" disease_type="Disease or Syndrome" abbrv="">rheumatic disease</z:e> groups </plain></SENT>
<SENT sid="14" pm="."><plain>Ethnic and/or geographical factors could be important in this syndrome </plain></SENT>
<SENT sid="15" pm="."><plain>To the best of our knowledge, this is the first report of <z:e sem="disease" ids="C0796280" disease_type="Disease or Syndrome" abbrv="">Hughes syndrome</z:e> from the Middle East </plain></SENT>
</text></document>